Aprogen Biologics Inc. (KRX:003060)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,085.00
+20.00 (0.97%)
Jul 1, 2026, 3:30 PM KST

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Pharmaceutical Business Division
57.19B57.57B62.95B64.74B55.74B
Pharmaceutical Business Division Growth
-0.67%-8.55%-2.76%16.14%9.74%
Bio Business Division
5.58B9.45B16.87B274.43M-
Bio Business Division Growth
-40.99%-44.00%6047.42%--
Semiconductor Business Division
9.64B----
Other Sales
829.33M358.95M812.16M--
Other Sales Growth
131.04%-55.80%---
Game Business Division
--357.66M173.22M738.18M
Game Business Division Growth
--106.48%-76.53%-70.76%
Insulation Business Division
--6.37B--
Total
73.23B67.38B87.36B65.19B56.48B
Total Growth
8.68%-22.88%34.01%15.42%5.93%